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ABSTRACT 
The Fast Dissolving Drug Delivery Systems sets a new benchmark was an expansion that came into existence in the early 1980’s 
and combat over the use of the different dosage form like tablets, suspension, syrups, capsules which are the other oral drug 
delivery systems. Fast Dissolving Drug Delivery System (FDTS) has a major advantage over the conventional dosage forms since 
the drug gets rapidly disintegrated and dissolves in the saliva without the use of water .In spite of the downside lack of immediate 
onset of action; these oral dosage forms have valuable purposes such as self medication, increased patient compliance, ease of 
manufacturing and lack of pain. Hence Fast Disintegrating Tablets (FDTS) technology has been gaining importance now-a-days 
with wide variety of drugs serving many purposes. Fast Disintegrating Tablets (FDTS) has ever increased their demand in the last 
decade since they disintegrate in saliva in less than a minute that improved compliance in pediatrics and geriatric patients, who 
have difficulty in swallowing tablets or liquids. As fast dissolving tablet provide instantaneous disintegration after putting it on 
tongue, thereby rapid drug absorption and instantaneous bioavailability, whereas Fast dissolving oral films are used as practical 
alternative to FDTS. These films have a potential to deliver the drug systemically through intragastric, sublingual or buccal route 
of administration and also has been used for local action. 
In present review article different aspects of fast dissolving tablets and films like method of preparations, latest technologies, and 
evaluation parameters are discussed. This study will be useful for the researchers for their lab work. 
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INTRODUCTION 
At present scenario formulation research is modified in 
such a way that the active ingredients can be delivered 
to the target site with a level of convenience, 
performance and improved bioavailability
1
. As the cost 
for developing a generic molecule is too expensive, the 
research is being done on the new dosage forms for 
having better patient compliance as compared to the 
different dosage forms of which the oral route serves to 
make a provenance. The oral route of administration is 
always considered to be the most preferred route 
because of its various advantages like ease of 
administration, pain avoidance, versatility and most 
important patient compliance
2
.  
Dysphagia and Fast-dissolving tablets-Dysphagia is 
the term used to describe difficulty swallowing. 
Dysphagia includes difficulty starting a swallow 
(called oropharyngeal dysphagia) and the sensation of 
food being stuck in the neck or chest (called 
esophageal dysphagia)
3
.  
Tablet is the most popular and common dosage form. 
However some limitations are associated with it like, 
large size of dosage forms, and in some cases as of 
uncooperative, pediatric and dysphagia patients, it may 
create some problems. Moreover traveling patients 
suffering from motion sickness and diarrhea don’t have 
easy access to water for oral drug administration. 
To overcome these problems, a new modified form of 
tablets is developed, which is known as fast dissolving 
tablet or mouth dissolving tablet
4
. Fast-dissolving 
tablets (FDTS) disintegrate and/or dissolve 
instantaneously in the saliva without the use of water. 
FDTS are best alternative for all of these patients. The 
Center for Drug Evaluation and Research (CDER), US 
FDA defined Oral Disintegrating Tablets (ODT) as a 
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solid dosage form containing medicinal substances, 
which disintegrates rapidly, usually within a matter of 
seconds, when placed upon the tongue
5
.  
The disintegration time of such tablets is very short 
because of their highly porous structure and the high 
solubility of the sugar alcohol or saccharide present as 
the diluents. 
Drug gets released after rapidly disintegration rapidly; 
drugs are absorbed from the mouth, pharynx and 
esophagus as the saliva passes down into the stomach
6
.
 
Most fast dissolving drug delivery system films consist 
of different substances to mask the bitter taste of active 
ingredient. This masked active ingredient is than 
swallowed by the patient’s saliva along with the 
soluble and insoluble excipients. These are also called 
as melt-in-mouth tablets, repimelts or porous tablets. 
Advantages of FDTS 
1. No need of water and chewing. 
2. Better taste masking properties. 
3. Beneficial in cases such as motion sickness, 
sudden  episodes of allergic attack or coughing. 
4. Ease of   administration to patients who cannot 
swallow like the bed-ridden, stroke victims and 
patients who refuse to swallow like geriatrics, 
pediatrics and psychiatrics. 
5. Stability can be improved7. 
6. Acceptable taste and pleasant mouth feeling. 
7. Dissolution and absorption of drug is fast, 
offering rapid onset of action. 
8. Bioavailability of drugs is increased by avoiding 
first pass metabolism. 
9. High drug loading can be possible. 
10. No specific packaging is required. It can be 
packaged in push through blisters. 
11. Minimum risk of suffocation in airways due to 
physical obstruction, when ODTs are swallowed, 
thus they provide improved safety and 
compliance with their administrations
8
. 
Disadvantages of FDTS 
1. These tablets usually have insufficient mechanical 
strength. Hence, careful handling is required.  
2. Fast dissolving tablets requires special kind of   
packaging for proper stabilization and safety of 
stable product
9
. 
3. Drugs with relatively larger doses are difficult to 
formulate into MDT e.g. antibiotics like 
amoxicillin with adult dose tablet containing 
about 500 mg of the drug. 
4. Tablets may leave unpleasant taste and/or 
grittiness in mouth if not formulated properly. 
5. Patients with Sjogren’s syndrome or dryness of 
the mouth due to decreased saliva production may 
not be good candidates for these tablet 
formulations
10
. 
6. They are more susceptible to degradation by 
humidity and temperature. Fast dissolving tablets 
are hygroscopic in nature so must be keep in dry 
place. 
7. Drugs with short half-life and frequent dosing and 
those whom require controlled or sustained 
release are unsuitable candidates of FDTS. 
 
 
CHALLENGES FOR DEVELOPMENT OF FDTS  
1. Taste masking  
Undesirable taste is one of the important formulation 
problems that are encountered with many drugs. Bitter 
drugs in the form of FDTS can’t be accepted by the 
patients. Administration of bitter drugs orally with 
acceptable level of palatability is the aim of all 
manufacturers. As most drugs are unpalatable, rapid 
disintegrating drug delivery systems usually contain 
the medicament in a taste- masked form. Delivery 
systems disintegrate or dissolve in patient’s oral cavity, 
thus releasing the active ingredients which come in 
contact with the taste buds; hence, taste-masking of the 
drugs becomes critical to patient compliance.  
Taste-masking technologies are being used for bitter-
tasting drugs like the macrolide antibiotics, non-
steroidal anti-inflammatory drugs, and penicillins. 
However taste masking of water-soluble bitter drugs, 
with a high dose, is difficult to achieve by using 
sweeteners alone
11
. 
2. Hygroscopicity  
It is the capacity of a product (e.g. cargo, packaging 
material) to react to the moisture content of the air by 
absorbing or releasing water vapor. Hygroscopicity is, 
of course, an important characteristic of a powder. It 
can be shown, roughly, for a fairly soluble compound 
that the hygroscopicity is related to its solubility. FDTS 
should have low sensitivity to humidity. This problem 
can be especially challenging because many highly 
water soluble excipients are used in formulation. 
Highly water-soluble excipients are susceptible to 
moisture; some will even deliquesce at high humidity. 
A good package design or other strategy should be 
followed to protect FDTS from atmospheric 
conditions
12
. 
3. Mouth feel 
The particles generated after disintegration of the 
FDTS should be as small as possible in oral cavity for 
the good feeling. Moreover addition of flavors and 
cooling agents like menthol improve the mouth feel
13
. 
4. Aqueous solubility  
Water-soluble drugs pose various formulate ion 
challenges because they form eutectic 
mixtures, which result in freezing-point depression and 
the format ion of a glassy solid that may collapse upon 
drying because of loss of supporting structure during 
the sublimate ion process. Such collapse sometimes 
can be prevented by using various matrix-forming 
excipients such as mannitol than can induce 
crystallinity and hence, impart rigidity to the 
amorphous composite
14
. 
5. Amount of drug 
For lyophilized dosage forms, the drug dose must be 
lower than 400 mg for insoluble drugs and less than 60 
mg for soluble drugs. This parameter is particularly 
challenging when formulating a fast-dissolving oral 
films or wafers. The application of technologies used 
for FDTS is limited by the amount of drug that can be 
incorporated into each unit dose
15
. 
6. Mechanical strength and disintegration time  
FDTS are formulated to obtain disintegration time 
usually less than a minute. FDTS dissolves or 
disintegrates quickly in the oral cavity upon the contact 
Singh et al.                                                                         Universal Journal of Pharmaceutical Research                          
   
 ISSN: 2456-8058                                                           62                                     CODEN (USA): UJPRA3    
with saliva, resulting in solution or suspension of the 
administered medicine. It is obvious that increasing the 
mechanical strength will delay the disintegration time. 
So a good compromise between these two parameters 
is always essential. While doing so, maintaining a good 
mechanical strength is a prime challenge
16
. 
7. Cost 
The technology used for FDTS should be economical. 
Special technologies used may increase the cost of 
final products. 
 
TECHNOLOGIES FOR PREPARATION OF 
FDTS 
A. Non-patented Technologies 
1. Direct Compression 
Direct compression is the easiest way to manufacture 
tablets. Direct compression is viewed as the technique 
of choice for the manufacture of tablets containing 
thermolabile and moisture-sensitive drugs The great 
advantage of direct compression is the low 
manufacturing cost. It uses conventional equipment, 
commonly available excipients, and a limited number 
process steps. Single or combined action of 
disintegrants, water soluble excipients and effervescent 
agents depends on the disintegration and solubilization 
of directly compressed tablets. Breakage of tablet 
edges during handling and tablet crack during the 
opening of blister alveolus, all result from insufficient 
physical resistance protection
17
. 
2. Tablet Moulding 
Tablets prepared by this method are solid dispersions. 
Molded tablets are less compact than compressed 
tablets, with a porous structure that facilitates rapid 
disintegration and easy dissolution. Molded tablets 
offer improved taste due to water-soluble sugars 
present in dispersion matrix. Moulding technique is of 
two types
18
. 
a. Solvent method 
 In this technique damping the powder blend is done by 
an alcoholic solvent and then compressing at low 
pressure in molded plates to form a wet mass. After air 
drying tablets prepared by this technique are less 
compact than compressed tablets and posses a porous 
structure that accelerates the dissolution
19
.  
b. The heat process 
It  involves preparation of a suspension that contains a 
drug, agar and sugar and pouring the suspension in the 
blister packaging wells, solidifying the agar at the room 
temperature to form a jelly and drying at 30ºC under 
vacuum. The mechanical strength of molded tablets is 
to be notified and hence binding agents are mixed to 
give strength. Taste masking is an additional trouble in 
this technology. The taste masked drug particles were 
prepared by spray congealing a molten mixture of 
hydrogenated cottonseed oil, sodium carbonate, 
lecithin, polyethylene glycol and an active ingredient 
into a lactose based tablet triturate form
20
. 
3. Spray Drying
 
For producing porous and fine powders that dissolve 
rapidly spray drying technique is used. The 
formulations are included by hydrolyzed and non 
hydrolyzed gelatins as supporting agents, mannitol as 
bulking agent, sodium starch glycolate or 
croscarmellose sodium as disintegrating and an acidic 
material (e.g. citric acid) and/ or alkali material (e.g. 
sodium bicarbonate) to improve disintegration and 
dissolution. This formulation technique gives porous 
powder and disintegration time < 20 sec
17
. 
4. Sublimation 
The key to rapid disintegration for mouth dissolving 
tablets is the presence of a porous structure in the tablet 
matrix. Conventional compressed tablets that contain 
highly water-soluble ingredients often fall to dissolve 
rapidly because of low porosity of the matrix. 
Highly volatile ingredients like ammonium 
bicarbonate, ammonium carbonate, benzoic acid, 
menthol, camphor, naphthalene, urea, urethane or 
phthalic anhydride could be compressed along with 
other excipients into a tablet. The volatile material is 
then removed by sublimation leaving behind a highly 
porous matrix. Tablets manufactured by this technique 
are reported to usually disintegrate in 10- 20 sec. and 
exhibit sufficient mechanical strength
16
.  
5. Lyophilization or freeze drying 
A process in which water is sublimated from the 
product after freezing is called freeze drying. Freeze 
dried forms offer more rapid dissolution than other 
available solid products. The tablets are very porous in 
nature and dissolve quickly when come in contact with 
salivary the lyophilization technique. The active drug is 
dispersed in an aqueous solution of a carrier which is a 
polymer
15
. First the trays having sample are freeze in 
blister packs by passed through liquid nitrogen freezing 
tunnel to freeze the drug solution or dispersion. First of 
all, the material is frozen to bring it below its eutectic 
point. This primary drying is done to decrease the 
moisture to about 4% w/w of dry product. By repeating 
secondary drying which reduce the bound moisture to 
the required volume of the drug product. However the 
use of freeze-drying is restricted due to high cost of 
equipment and processing. The freeze- drying 
technique has demonstrated improved absorption and 
increase in bioavailability. A major limitation of the 
final dosage form comprises lack of physical resistance 
in standard blister packs
21
. 
6. Melt Granulation 
Melt granulation technique is a process by which 
pharmaceutical powders are efficiently agglomerated 
by a meltable binder. It is a technique useful to enhance 
the dissolution rate of poorly water-soluble drugs, such 
as griseofulvin. There is no need of drying that is main 
benefit of the melt granulation technique benefit is 
compared to a conventional granulation is that no water 
or organic solvents is required. Since there is no drying 
step, the process is less time consuming and requires 
less energy than wet granulation
22
.  
7. Mass extrusion 
In mass extrusion technique solvent mixture of water-
soluble polyethylene glycol and methanol are used for 
softening the blend of drug and consequent removal of 
softened mass through the extruder or syringe to get a 
cylinder of the product into even segments using 
heated blade to form tablet. The dried cylinder can also 
be used to coat granules for bitter drugs and thereby 
achieving taste masking
22,25
. 
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8. Cotton candy process/ candy floss process 
In this technology, the matrix is formed from 
saccharides or polysaccharides processed into an 
amorphous floss through a shear foam process. This 
technique makes use of a unique spinning mechanism 
to produce floss-like crystalline structure, which mimic 
cotton candy that’s why this is called Cotton candy 
process involves the formation of matrix of 
polysaccharides or saccharides by simultaneous action 
of flash melting and spinning
23
. 
B. Patented Technologies 
1. Lyoc 
Lyoc technology is patented by Pharmalyco. Lyoc 
utilizes a freeze drying process but it differs from Zydis 
in that the product is frozen on the freeze dryer shelves. 
In order to prevent homogeneity by sedimentation 
during this process, these formulations also require a 
large proportion of undissolved inert filler such as 
mannitol, to increase the viscosity of the in process 
suspension. The high proportion of filler used reduces 
the potential porosity of the dried dosage form and 
hence results in denser tablets with disintegration rates 
that are comparable with the loosely compressed fast 
melt formulations
24
. 
2. Wow tab Technology 
Wowtab technology is patented by Yamanouchi 
Pharmaceutical Co. The WOW in Wowtab signifies the 
tablet is to be given “With Out Water”. It consist of 
combination of low- moldability saccharides  like 
lactose, mannitol, glucose, sucrose, and xylitol and 
high-moldability saccharides like maltose, sorbitol, and 
oligosaccharides in order to produce fast dissolving 
tablets using conventional granulation and tableting 
techniques
4,6,9
.  
3. Flash dose technology 
Flash dose technology has been patented by Fuisz 
Technologies Ltd. It uses a unique spinning mechanism 
so as to produce a floss-like crystalline structure, much 
like cotton candy. The Flash dose tablets consist of 
self–binding shear form matrix termed as “floss. This 
crystalline sugar can then incorporate the drug and be 
compressed into a tablet. The final product which is 
being produced has a very high surface area for 
dissolution. It disperses and dissolves quickly once 
placed on the tongue
25
.  
4. DuraSolv technology 
DuraSolv R technology was developed by Ciba to 
provide stronger tablets for packaging in blisters or 
bottles. DuraSolv is so durable that it can be packaged 
in either traditional blister packaging or vials. The key 
ingredients in this formulation are filler and lubricant.  
The tablets have low friability (about 2%) .The 
disintegration time is less than 60 seconds. This 
method can produce tablets by using the direct 
compression method, conventional tableting 
methodologies and conventional package equipment. 
Thus, the production cost is significantly reduced
26
. 
5. Quicksolv technology 
Quicksolv technology is patented by Janssen 
Pharmaceutica, Beese, Belgium. This method claimed 
to prevent or to reduce the incidence of cracking during 
the final preparation, having uniform porosity and also 
the adequate strength for handling. 
In this technology, the matrix compositions are 
dissolved in the solvent (usually water), and then this 
solution is frozen
3,7
.  The  first solvent will remain in 
the solid form, and then the frozen solution contacts the 
second solvent which is usually, ethanol, menthol, or 
acetone. Thus, the first solvent is removed after a few 
hours of contacting the second solvent to result in a 
usable matrix. The final product disintegrates almost 
instantly
27
.  
6. Ziplets/Advatab 
This technology is patented by Passano con Barnago, 
Italy. In this technique water-insoluble ingredient are 
merged with one or more effective disintegrants to 
produce ODT with improved mechanical strength and 
optimal disintegration time at low compression force
28
. 
7. Nanocrystal technology 
This is patented by Elan, King of Prussia. In this 
technique, crystal colloidal dispersions of the drug 
substances are combined with water soluble 
ingredients, followed by filling into blister and 
lyophillization. This technique avoids manufacturing 
processes such as granulation, blending, and tableting, 
which is more advantageous for highly potent and 
hazardous
29
.  
8. OraSolv technology 
OraSolv was Cima's first fast-dissolving/disintegrating 
dosage form. This includes the use of effervescent 
disintegrating agents which is compressed with low 
pressure to produce the fast dissolving tablets. Tablets 
are made by direct compression technique at low 
compression force in order to minimize oral dissolution 
time. The evolution of carbon dioxide from the tablet 
produces a fizzing sensation, which is a positive 
organoleptic property. The limitation associated is that 
the tablets produced are soft and friable
9
. 
9. Pharmabrust technology 
Pharmaburst technology is being patented by SPI 
pharma. By this methodology tablets have sufficient 
strength and can be packed in blister packs and bottles. 
The tablet manufactured by this process involves a dry 
blend of a drug, flavors, and lubricant then followed by 
compression into tablets which then dissolve within 30-
40 seconds
5
. 
 10. Zydis technology 
Scherer has patented the Zydis technology. In this the 
drug is produced by freeze drying or lyophilizing the 
drug in gelatin matrix. The product thus produced is 
very light weight and packed in blister packs. Patients 
should be advised not to push the tablets through the 
foil film, but instead peel the film back to release the 
tablet. This technique mask the bitter taste of drug by 
means of microencapsulation using specialized 
polymers and resins. This technique is quite expensive. 
Zydis formulation should be used within six month 
after opening. This technology claims for increased 
bioavailability as compared to other conventional 
tablets. The main advantage of this technology is 
convenience and disadvantage is that the freeze drying 
process is quite expensive manufacturing process
30
.  
11. Quick-dis technology 
This technology is a proprietary patented technology of 
Lavipharm Laboratories. It is a thin, flexible, and quick 
dissolving film. The film is placed on the top or the 
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floor of the tongue. It is retained at the site of 
application and rapidly releases the active agent for 
local and/or systemic absorption. 
12. Flash tab technology 
Prographarm laboratories has patented the Flashtab 
technology. This technology engages in the preparation 
of rapidly disintegrating tablet which consists of an 
active ingredient in the form of microcrystals. To 
prepare drug microgranules all the processing utilized 
conventional tabletting technology like coacervation, 
extrusion-spheronization, simple pan coating methods 
and microencapsulation. Disintegration time of these 
tablets is less than one minute
31
. 
13. Frosta technology 
This technology is patented by Akina. Plastic granules 
are prepared and compressed at low pressure to 
produce strong tablets with high porosity. The process 
involves mixing the porous plastic material with water 
penetration enhancer followed by granulating with 
binder. The tablets obtained have excellent hardness 
and rapid disintegration time ranging from 15 to 30 sec 
depending on size of tablet
32
. 
 
EVALUATION OF FAST DISSOLVING TABLET  
1. Weight variation 
20 tablets were selected randomly from the lot and 
weighted individually to check for weight variation. 
Deviation of ±10% is allowed for tablet of less than or 
equal to 80mg, ±7.5% deviation is allowed for tablet in 
between 80 to 250 mg. For a tablet of more than 250 
mg, ±5% deviation is allowed
33
. 
2. Tensile Strength 
Tensile strength is the measure of force required to 
break a tablet by compressing it in the radial direction 
and is measured using a tablet hardness tester. The 
plunger of the hardness tester is driven down at a speed 
of 20 mm/min for measuring the hardness of the 
tablets
34
.  
3. Friability 
The friability test for a tablet is carried out and the limit 
is not more than 1% using tablet friability apparatus, 
carried out at 25 rpm for 4 min (100 rotations). Big 
challenge for a formulator is that how to achieve 
friability within this limit for FDT product keeping 
hardness at its lowest possible level in order to achieve 
a minimum possible disintegration time. This test is 
again not applicable for lyophilized and flash dose 
tablets, but is always recommended for tablets prepared 
by direct compression and moulding techniques
11,15
. 
4. Moisture Uptake Study 
Mouth Dissolving Tablets have high concentration of 
hydrophilic excipients with the minimum possible 
hardness which together contributes to their increased 
susceptibility to moisture uptake hence special 
attention is required during the storage and packaging 
of these dosage forms. The test can be carried out by 
keeping ten tablets along with calcium chloride in a 
dessicator maintained at 37°C for 24 hr to ensure 
complete drying of the tablets. The tablets are then 
weighed and exposed to 75% RH, at room temperature 
for 2 weeks. For achieving the required humidity keep 
saturated sodium chloride solution in the dessicator for 
24 hr. The tablets are reweighed and the percentage 
increase in weight is recorded
35
. 
5. Tablet Porosity 
The mercury penetration porosimeter can be used to 
measure the tablet porosity which is a relative 
assessment of the degree of water penetration in the 
formulation, responsible for its fast disintegration
9,16
.  
6. Wetting Time and Water Absorption Ratio 
This study is carried out by using a piece of double 
folded tissue paper placed in a petridish containing 6 
ml of water. One tablet was placed on this paper and 
the time for complete wetting of tablet was noted as 
wetting time. The wetted tablet was then weighed and 
the water absorption ratio, R, was determined 
according to equation. 
R =
Wa− Wb
Wb
X100 
Where Wb and Wa are the weights of tablet before and 
after water absorption respectively. Where R is water 
absorption ratio
28
. 
7. In-vivo disintegration time 
The time for disintegration of Orally Disintegrating 
tablets is less than one minute and in actual it is just 5 
to 30 seconds time duration for the disintegration
25,26
.  
8. Dissolution Test 
The development of dissolution methods for Orally 
Dissolving Tablets and conventional tablet are similar. 
Dissolution conditions for drugs listed in a 
pharmacopoeia monograph, is a good place to start 
with scouting runs for a bioequivalent orally dissolving 
tablets. Other media such as 0.1N HCl and buffers (pH 
- 4.5 and 6.8) should be evaluated for orally dissolving 
tablets much in the similar way as conventional tablets. 
USP dissolution apparatus 1 and 2 can be used for this 
study. USP 1 Basket apparatus may have certain 
applications, but sometimes, tablet fragments or 
disintegrated tablet masses may become trapped on the 
inside top of the basket at the spindle where little or no 
effective stirring occurs, yielding irreproducible 
dissolution profiles. USP 2 Paddle apparatus, which is 
the most suitable and common choice for ODTs, with a 
paddle speed of 50 rpm commonly used. Typically, the 
dissolution of tablets is very fast when using USP 
monograph conditions; hence, slower paddle speeds 
may be utilized to obtain a profile. The USP 2 Paddle 
apparatus at 50 to 100 rpm is suitable for dissolution 
testing of taste-masked drug as well
36, 37
. 
 
FAST DISSOLVING ORAL FILMS 
Fast dissolving oral films (FDOFs) are the most highly 
developed form of oral solid dosage form due to more 
flexibility and comfort. It improves the efficacy of 
drugs by dissolving within 60 seconds in oral cavity 
after the contact with saliva without chewing and no 
need of water for administration
38
. It gives rapid 
absorption and instant bioavailability of drugs due to 
high blood flow and permeability. FDOFs are useful in 
patients such as pediatric, geriatrics, bedridden, emetic 
patients, diarrhea, sudden episode of allergic attacks, or 
coughing for those who have an active life style. Fast 
dissolving oral films are based on the technology of the 
transdermal patch. Sometimes taste masking agents are 
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also added to mask the taste of the active ingredient
34
. 
Fast dissolving oral films have advantages like:  
1. Thin film is more stable, durable and quick 
dissolving than other conventional dosage forms. 
2. Improved dosage accuracy as compared to liquid 
formulations. 
3. No need of water with improved patient 
compliance. Does not interfere with normal 
function like talking, drinking etc
11
. 
4. Accessibility of larger surface area that leads to 
quickly disintegrate and dissolution in the oral 
cavity within seconds. 
5. No first-pass hepatic metabolism thus improved 
bioavailability
25
. 
6. Ease of handling and transportability. 
7. Pleasant mouth feel 
 
FORMULATION METHODOLOGY FOR FAST 
DISSOLVING FILMS  
1. Solvent casting method 
In solvent casting method water soluble polymers are 
dissolved in water and the drug along with other 
excipients is dissolved in suitable solvent then both the 
solutions are mixed and stirred and finally casted in to 
the Petri plate dried and cut in to uniform dimensions
38
.
 
2. Semisolid casting 
In semisolid casting method firstly a solution of water-
soluble film forming polymer is prepared. The 
resulting solution is added to a solution of acid 
insoluble polymer (e.g. cellulose acetate phthalate, 
cellulose acetate butyrate), which was prepared in 
ammonium or sodium hydroxide. Then appropriate 
amount of plasticizer is added so that a gel mass is 
obtained. Finally the gel mass is casted in to the films 
or ribbons using heat controlled drums. The thickness 
of the film is about 0.015-0.05 inches. The ratio of the 
acid insoluble poly merto film forming polymer should 
be 1:4
39
. 
3. Hot melt extrusion 
In hot melt extrusion method firstly the drug is mixed 
with carriers in solid form. Then the extruder having 
heaters melts the mixture. Finally the melt is shaped in 
to films by the dies.  
4. Solid dispersion extrusion 
In this method immiscible components are extrude with 
drug and then solid dispersions are prepared. Finally 
the solid dispersions are shaped in to films by means of 
dies 
5. Rolling method 
In rolling method a solution or suspension containing 
drug is rolled on a carrier. The solvent is mainly water 
and mixture of water and alcohol. The film is dried on 
the rollers and cut in to desired shapes and sizes
16,17
. 
 
TECHNOLOGIES FOR FAST DISSOLVING 
FILMS 
1. Wafer Tab 
Wafer Tab is a drug delivery system which 
incorporates pharmaceutical actives into an ingestible 
film strip. It provides rapid dissolution and release of 
active pharmaceutical ingrdient when the strip comes 
into contact with saliva in the mouth. The WaferTab 
film strip can also be flavoured for additionally 
improved taste-masking. The active ingredient is 
integrated into the body of a fused. The film can be 
prepared in a variety of shapes and sizes and is an ideal 
method for deliverying medicines which require fast 
release and also for use by patients who have difficulty 
swallowing
40
. 
2. XGEL 
XGel film Technology developed by BioProgress was 
causing a revolution in 
the product offerings and manufacturing methods. It is 
nonanimal-derived, approved on religious grounds and 
is suitable for vegetarians. These film can be taste 
masked, coloured, layered, and capable of being enteric 
properties whilst also having the ability to incorporate 
active pharmaceutical ingredients. The XGEL™ film 
systems can be made to encapsulate any oral dosage 
form, and can be soluble in either cold or hot water
41
. 
3. Foamburst 
In this technology gas is blown into the film during 
production, resulting in a 
film with a honeycombed structure. The voids in the 
film may be gas-filled, empty 
or filled with other materials to produce specific taste-
burst characteristics or to 
deliver active drugs. The light honeycombed structure 
results in capsules that dissolve rapidly, causing a melt-
in-the mouth sensation. This technology has attracted 
interest from food and confectionary manufacturers as 
a means of carrying and releasing flavours
42
. 
4. Soluleaves 
This technology is used to produce a range of oral 
delivery films that can incorporate active 
 ingredients, colours and flavours. In this technology 
the film is produced in order to release the active 
ingredients on coming in contact with saliva. This 
method is especially useful for pediatric and geriatric 
patients who may have difficulty swallowing 
conventional tablets. These are designed in such a way 
that they adhere to mucous membrane in order to 
release the drug slowly in 15mins
43
. 
 
EVALUATION PARAMETERS 
1. Thickness 
The thickness of the patch is measured using digital 
Vernier Calliper with a least count of 0.01 mm at 
different spots of the film. The thickness was measured 
at three different spots of the patch and average was 
taken and SD was calculated
44
. 
2. Weight variation 
A particlular centimeter square of the film is cutted at 
different places from the casted film. The weight of 
each film is taken and weight variation is calculated
22
. 
3. Folding endurance 
Folding endurance is determined by repeated folding of 
the film at the same place till the strip breaks. The 
number of times the film is folded without breaking is 
computed as the folding endurance value
25
. 
4. Tensile strength 
Tensile strength is the maximum stress applied to a 
point at which the film specimen breaks
45
. It is 
calculated by the applied load at rupture divided by the 
cross-sectional area of the film as given below: 
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Tensile strength =
Load at failure
Film thickness X film width
X100 
5. Percent elongation 
A film sample stretches when stress is applied and it is 
referred to as strain. Strain is basically the deformation 
of film divided by original dimension of the sample. 
Elongation of film increases as the plasticizer content 
increases. 
% Elongation =
𝐿
𝐿𝑜
𝑋100 
Where, L = Increase in length of film,Lo = Initial 
length of film. 
6. Surface pH 
The film to be tested was placed in a petri dish and is 
moistened with 0.5ml of distilled water and kept for 
30sec. The pH is noted after bringing the electrode of 
the pH meter in contact with the surface of the 
formulation and allowing equlibriation for 1min
35
. 
7. Uniformity of drug content 
This parameter is determined by dissolving one film of 
dimension 2x2cm by homogenization in 100 ml of 
stimulated saliva of pH 6.8 for 30 min with continuous 
shaking. The absorbance was measured using an UV 
spectrophotometer
37
.  
8. In vitro dissolution studies 
Dissolution profile of fast dissolving films is carried 
out using USP type II (paddle apparatus) with 300 mL 
of simulated salivary fluid (pH 6.8) as dissolution 
medium maintained at 37 ± 0.50C. Medium was stirred 
at 100 rpm. Samples were withdrawn at every 30sec 
interval, replacing the same amount with the fresh 
medium. Amount of drug in the withdrawn samples 
was determined by UV spectrophotometer.  
9. Ex vivo permeation studies through porcine oral 
mucosa 
Permeation studies were carried using the modified 
Franz diffusion cell of specific internal diameter. The 
buccal pouch of the freshly sacrificed pig was procured 
from the local slaughter house. The buccal mucosa of 
the freshly sacrificed pig or mouse is used for this 
purpose and washed in isotonic phosphate buffer of pH 
6.6 and used immediately. Samples obtained are 
studied by UV spectrophotometer
46
. 
 
CONCLUSION 
Due to decline in dysphagia swallowing ability with 
age, many elderly patients complain that it is difficult 
for them to take some currently used dosage forms 
such as tablets, capsules, or powders, fast dissolving 
tablets are thus a best alternative of these dosage forms. 
These tablets are one of the most promising dosage 
forms in recent years; this type of tablet has attracted 
the interest of many researchers. Fast dissolving drug 
delivery system creates new plate form for better 
patient compliance, stabilizes drugs which facing 
difficulties in release pattern and may offer improved 
biopharmaceutical properties, improved efficacy and 
better safety compared with conventional oral dosage 
forms. Fast Dissolving Tablets formulations obtained 
by some of these technologies have sufficient 
mechanical strength, quick disintegration/dissolution in 
the mouth. An extension of market monopoly, which 
can be provided by a fast-dissolving tablets or oral, 
films/disintegrating dosage form, leads to increased 
revenue of the pharmaceutical company which is also 
leads to target underserved and undertreated patient 
populations. Their unbeatable advantages such as 
administration without water, anywhere, anytime lead 
to their suitability to geriatric and pediatric patients. 
Rapid onset, good stability and increased 
bioavailability lead to its current growth in the market 
which is extended day by day. Now a day’s new 
techniques are patented for the preparation of fast 
dissolving films and tablets day by day which is 
beneficiary for the pediatrics and geriatrics patient. 
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Table 1: Various ingredients of FDTS 
S. N. Types of ingredients % 
1.  Active pharmaceutical agent  1-25% 
2.  Water soluble film forming polymer 40-50% 
3.  Plasticizer 0-20 
4.  Sweetening agent 3-6% 
5.  Saliva stimulating agent 2-6% 
6.  Colors and Flavors 0-10% 
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Table 2: Composition of fast dissolving oral film 
S. N.  Ingredients  Quantity 
1.  
Active pharmaceutical 
agent  
1-25% 
2.  Film forming polymer  40-50% 
3.  Plasticizer  0-20% 
4.  
Saliva stimulating 
agent  
2-6% 
5.  Sweetening agent  3-6% 
6.  Flavoring agent  10% 
7.  Colouring agent  1% 
 
 
Table 3: Comparison between Fast Dissolving, Tablets and Films 
Criteria Fast Dissolving Tablets  Fast Dissolving Films 
Form It is a tablet  It is a film 
Thickness thickness 0.015-.05 inches Same size as of conventional tablet 
Dissolution 
Less dissolution due to less surface area  
Greater dissolution due to larger 
surface area 
Durability 
Less durable as compared with oral films  
Better durable than oral disintegrating 
tablets 
Patient 
compliance 
Less patient compliance than films  More patient compliance 
Dose size Large dose can be incorporated  Small dose can only be incorporated 
Chocking Fear of chocking is present No risk of chocking 
 
 
 
Table 4: Commercially available fast dissolving tablets
  
Brand name  Active ingredient Company  
Benadryl Fastmelt®  
Diphenhydramine 
Citrate 
Pfizer  
Childrens Dimetapp® 
ND  
Loratadine 
Wyeth consumer 
Healthcare 
Claritin® RediTabs®  Loratadine  Scherig corporation  
Domray MD Domperidone Ray remedies 
Dolib MD Rofecoxib Panacea 
Excedrin®QuickTabs  Acetaminophen  Bristol-Myers Squibb  
Felden FM Piroxicam Pfizer 
Gaster D  Famotidine  Yamanouchi  
Imodium Istant Melts  Loperamide HCL  Janssen  
Klonopin® wafer  Clonazepam  Roche  
Kozicold Nimesulide Kaizen Drugs 
Lonazep MD Olnazepine  Sun Pharma 
Maxalt –MLT  Rizatritpan benzoate  Merck  
Mosid MT Mosapride Torrent Pharma 
Nasea OD  Ramosetoron HCl  Yamanouchi  
Nimulid MD Nimesulide  Panacea 
Olanex Instab  Olanzapine  Ranbaxy Labs Ltd 
Ondem MD Ondensetron Alkem Pharma 
Pepcid RPD Famotidine  Merck Pharma 
Propulsid®Quicksolv ®  
Cisapride 
Monohydrate 
Janssen  
Remeron® Soltab®  Mirtazapine  Organon Inc.  
Resperdal®MTabTM  Resperidone  Janssen  
Rofixx MD Rofecoxib  Cipla Ltd. 
Romilast Montelucast Ranbaxy  
Tempra Quicksolv  Acetaminophen  Bristol-Mters squibb  
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Table 5: Examples of commercially available fast dissolving oral films 
Brand name  Active ingredient Company  
Benadryl Diphenhydramine HCl Pfizer 
Chloraseptic Benzocaine: Menthol Prestige 
Donepzil  Donepzil HCL  Labtec GmbH 
Eclipse3 Sugarfree mints  Wringley’s 
Gas-X Simethicone Novartis 
Listerine Cool mint  Pfizer 
Little Colds Pectin  Prestige brands 
Ondansetron  Ondensteron  Labtec GmbH 
Orazel Menthol/Pectin  Del 
Sudafed PE Phenylephrine HCl Pfizer 
Suppress Dextromethorphan InnoZen 
Theraflu Dextromethorphan HBr Novartis 
Triaminic Diphenhydramine HCl Novartis 
 
 
 
Torrox MT Rofecoxib Torrent 
Triaminic® 
Softchews®  
Various 
combination  
Novartis consumer Health  
Valus Valdecoxib  Galen Mark 
Vomidon MD Domperidone Olcare Lab 
ZelaparTM  Selegiline  Elanl Amarin corporation  
Zofer MD Ondansetron  Sun Pharma 
Zofex-25 MD Rofecoxib  Zota pharma  
Zontacet MD Cetrizine Zosta Pharma India 
ZubrinTM (Pet 
drug)  
Canine Tepoxelin  Scherig corporation  
Zyperxa®  Olazepine  Eli Lilly  
